LIGAND PHARMACEUTICALS INCORPORATED Lessee, Operating Lease, Liability, to be Paid, Year One
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.14 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-02-27
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.14M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.54M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.05M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.43M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $1.14M 10-K · filed 2026-02-27 |
| 2024-12-31 | $1.54M 10-K · filed 2025-02-28 |
| 2023-12-31 | $1.05M 10-K · filed 2024-02-29 |
| 2022-12-31 | $1.43M 10-K · filed 2023-02-28 |
| 2022-09-30 | $4.84M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.63M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.71M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.65M 10-K · filed 2022-02-28 |
| 2021-09-30 | $357.00K 10-Q · filed 2021-11-09 |
| 2020-12-31 | $2.26M 10-K · filed 2021-02-24 |
| 2019-12-31 | $1.91M 10-K · filed 2020-02-27 |